Andrew McCartney New Managing Director, International at Bioventus

Andrew McCartney is now Managing Director, International for Europe, Middle East and Africa (EMEA) at Bioventus LLC. As such, he will focus on growing the company’s active healing therapies portfolio within the region, as well as head up the international headquarters office in Hoofddorp, The Netherlands.

“We are very pleased Andrew is joining us to lead our growing business in EMEA, ” said company CEO Tony Bihl in the November 7, 2016 news release. “His broad and deep experience of the European healthcare market, business management and marketing will help us accelerate our growth in key international markets.”

McCartney joins Bioventus from Stryker Corporation, where for the past 10 years he progressively grew through leadership roles in sales, marketing and business unit management positions. He most recently served as vice president and general manager of the Surgical Division of Stryker Europe and previously was general manager, MedSurg, Stryker UK and Ireland.

Andrew McCartney told OTW, “The orthobiologics industry has a great opportunity to enhance patient lives through innovative technologies and treatment pathways. Bioventus is unique in that the company is 100% focused on becoming the global leader in orthobiologics, I believe that focus drives results and I have no doubt Bioventus will achieve this goal.”

“Having spent 20 years working in the medical device industry I have gained a good insight to the requirements of healthcare providers and the needs of payers. I have experience across a number of clinical specialties, including orthopedics and clinical settings in both primary and acute healthcare. I would say the experience that will support me best in this role is in talent management, my number one focus is to attract, develop and retain talented people that will ensure we provide our customers with best in class service and support and deliver on our commitments.”